Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REDWOOD, CHRISTOPHER EVAN | 1 | — | — |
| DEKARSKE, MADELINE MCGUIRE | 1 | 0.0% | +0.0% |
| GIAMMONA, FRANCESCA FILIPPA | 1 | 37.0% | +55.9% |
| RUIZ, JOSHUA DAMIAN | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18285820 | COMPOUND FOR PREVENTION OR TREATMENT OF KIDNEY DISEASE | DEKARSKE, MADELINE MCGUIRE | 23d overdue |
| 18278664 | METHOD FOR DETERMINING PRIMARY TUMOR SITE | GIAMMONA, FRANCESCA FILIPPA | 17d overdue |
| 18286068 | COMPOUND FOR PREVENTING OR TREATING DIABETES | REDWOOD, CHRISTOPHER EVAN | 9d overdue |
| 17918977 | METHOD FOR ESTIMATING TISSUE-LEVEL INFORMATION FROM CELLULAR-LEVEL INFORMATION, AND DEVICE THEREFOR | RUIZ, JOSHUA DAMIAN | 14d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18278664 | METHOD FOR DETERMINING PRIMARY TUMOR SITE | GIAMMONA, FRANCESCA FILIPPA | 17d overdue |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| 1622 | 1 |
| 1681 | 1 |
| 3684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18286068 | COMPOUND FOR PREVENTING OR TREATING DIABETES | REDWOOD, CHRISTOPHER EVAN | 1629 | §103§112 | Non-Final OA | 9d overdue | Pending | Oct 06, 2023 |
| 18285820 | COMPOUND FOR PREVENTION OR TREATMENT OF KIDNEY DISEASE | DEKARSKE, MADELINE MCGUIRE | 1622 | §103§112Other | Non-Final OA | 23d overdue | Pending | Oct 05, 2023 |
| 18278664 | METHOD FOR DETERMINING PRIMARY TUMOR SITE | GIAMMONA, FRANCESCA FILIPPA | 1681 | §101§102§112Other | Non-Final OA | 17d overdue | Pending | Aug 24, 2023 |
| 17918977 | METHOD FOR ESTIMATING TISSUE-LEVEL INFORMATION FROM CELLULAR-LEVEL INFORMATION, AND DEVICE THEREFOR | RUIZ, JOSHUA DAMIAN | 3684 | §103 | Final Rejection | 14d | Pending | Oct 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial